1. Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis 
Atsushi Tanaka, Susumu Tazuma, Kazuichi Okazaki, Takahiro Nakazawa, Kazuo Inui, Tsutomu Chiba, Hajime Takikawa 
Clinical Gastroenterology and Hepatology 
Volume 15, Issue 6, Pages e3 (June 2017)
DOI: /j.cgh
Copyright © 2017 AGA Institute Terms and Conditions

2. Figure 1
Distribution of age at presentation, for patients with IgG4-related sclerosing cholangitis.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

3. Figure 2
Symptoms at presentation, for patients with IgG4-related sclerosing cholangitis.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

4. Figure 3
Distribution of cholangiographic findings in patients with IgG4-related sclerosing cholangitis, according to the classification proposed by Nakazawa et al.23
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

5. Figure 4
The cumulative overall survival rate for patients with IgG4-related sclerosing cholangitis.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

6. Figure 5
The cumulative survival free from death caused by liver-related or bile duct–related diseases for patients with IgG4-related sclerosing cholangitis.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

7. Supplementary Figure 1
Serum alkaline phosphatase levels at presentation in patients with IgG4-related sclerosing cholangitis.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

8. Supplementary Figure 2
Serum IgG4 levels at presentation in patients with IgG4-related sclerosing cholangitis.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

9. Supplementary Figure 3
The cumulative rate of restenosis in patients with IgG4-related sclerosing cholangitis.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

10. Supplementary Figure 4
The cumulative survival free from death due to liver or bile duct-related diseases, stratified according to the presence of restenosis.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions